Vaga S, Lee S, Ji B, Andreasson A, Talley NJ, Agréus L, et al. Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals. Sci Rep. 2020;10(1):14977. https://doi.org/10.1038/s41598-020-71939-2. (PubMed PMID: 32917913; PubMed Central PMCID: PMC7486370).
Article PubMed PubMed Central Google Scholar
Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020;51(6):582–602. https://doi.org/10.1111/apt.15650. (PubMed PMID: 32056247).
Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006;103(3):732–7. https://doi.org/10.1073/pnas.0506655103. (PubMed PMID: 16407106; PubMed Central PMCID: PMC1334644).
Article CAS PubMed PubMed Central Google Scholar
Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19(Suppl 1):S37-43 (PubMed PMID: 7762738).
Kim N. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism. J Gastroenterol Hepatol. 2019;34(8):1287–95. https://doi.org/10.1111/jgh.14646. (PubMed PMID: 30828872).
Article CAS PubMed Google Scholar
Liu C, Ng SK, Ding Y, Lin Y, Liu W, Wong SH, et al. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis. Oncogene. 2022;41(28):3599–610. https://doi.org/10.1038/s41388-022-02377-9. (PubMed PMID: 35680985; PubMed Central PMCID: PMC9270228).
Article CAS PubMed PubMed Central Google Scholar
Park JY, Seo H, Kang CS, Shin TS, Kim JW, Park JM, et al. Dysbiotic change in gastric microbiome and its functional implication in gastric carcinogenesis. Sci Rep. 2022;12(1):4285. https://doi.org/10.1038/s41598-022-08288-9. (PubMed PMID: 35277583; PubMed Central PMCID: PMC8917121).
Article CAS PubMed PubMed Central Google Scholar
Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020;52(2):335–50. https://doi.org/10.4143/crt.2020.206. (PubMed PMID: 32178489; PubMed Central PMCID: PMC7176962).
Article PubMed PubMed Central Google Scholar
Kim JL, Kim SG, Lee A, Choi J, Chung H, Cho SJ. Long-term natural history after endoscopic resection for gastric dysplasia. Surg Endosc. 2021;35(9):5247–55. https://doi.org/10.1007/s00464-020-08023-3. (PubMed PMID: 32989550).
Kim SG, Lyu DH, Park CM, Lee NR, Kim J, Cha Y, Jung HY. Current status of endoscopic submucosal dissection for early gastric cancer in Korea: role and benefits. Korean J Intern Med. 2019;34(4):785–93. https://doi.org/10.3904/kjim.2017.374. (PubMed PMID: 29921044; PubMed Central PMCID: PMC6610182).
Nishizawa T, Yahagi N. Long-term outcomes of using endoscopic submucosal dissection to treat early gastric cancer. Gut Liver. 2018;12(2):119–24. https://doi.org/10.5009/gnl17095. (PubMedPMID:28673068;PubMedCentralPMCID:PMC5832335).
Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter. 2008;13(4):245–55. https://doi.org/10.1111/j.1523-5378.2008.00604.x. (PubMed PMID: 18665932).
Ortigão R, Figueirôa G, Frazzoni L, Pimentel-Nunes P, Hassan C, Dinis-Ribeiro M, et al. Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis. Endoscopy. 2022;54(9):892–901. https://doi.org/10.1055/a-1724-7378. (PubMed PMID: 35104897).
Li Q, Yu H. The role of non-H pylori bacteria in the development of gastric cancer. Am J Cancer Res. 2020;10(8):2271–81.
CAS PubMed PubMed Central Google Scholar
Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, et al. Screening and eradication of helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020;69(12):2093–112. https://doi.org/10.1136/gutjnl-2020-322368. (PubMed PMID: 33004546).
Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012;75(1):39–46. https://doi.org/10.1016/j.gie.2011.08.030. (PubMed PMID: 22018552).
Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187–94. https://doi.org/10.1001/jama.291.2.187. (PubMed PMID: 14722144).
Article CAS PubMed Google Scholar
Maeda M, Nakajima T, Oda I, Shimazu T, Yamamichi N, Maekita T, et al. High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study. Gut. 2017;66(9):1721–3. https://doi.org/10.1136/gutjnl-2016-313387. (PubMed PMID: 28003322; PubMed Central PMCID: PMC5561365).
Nakajima T, Enomoto S, Yamashita S, Ando T, Nakanishi Y, Nakazawa K, et al. Persistence of a component of DNA methylation in gastric mucosae after helicobacter pylori eradication. J Gastroenterol. 2010;45(1):37–44. https://doi.org/10.1007/s00535-009-0142-7. (PubMed PMID: 19821005).
Article CAS PubMed Google Scholar
Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K, Ushijima T. The presence of a methylation fingerprint of helicobacter pylori infection in human gastric mucosae. Int J Cancer. 2009;124(4):905–10. https://doi.org/10.1002/ijc.24018. (PubMed PMID: 19035455).
Article CAS PubMed Google Scholar
Park SY, Yoo EJ, Cho NY, Kim N, Kang GH. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for helicobacter pylori infection. J Pathol. 2009;219(4):410–6. https://doi.org/10.1002/path.2596. (PubMed PMID: 19639607).
Article CAS PubMed Google Scholar
Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci. 2010;101(1):36–45. https://doi.org/10.1111/j.1349-7006.2009.01383.x. (PubMed PMID: 19891661).
Article CAS PubMed Google Scholar
Shin CM, Kim N, Jung Y, Park JH, Kang GH, Kim JS, et al. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer Sci. 2010;101(6):1337–46. https://doi.org/10.1111/j.1349-7006.2010.01535.x. (PubMed PMID: 20345486).
Article CAS PubMed PubMed Central Google Scholar
Shin CM, Kim N, Jung Y, Park JH, Kang GH, Park WY, et al. Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer. Helicobacter. 2011;16(3):179–88. https://doi.org/10.1111/j.1523-5378.2011.00838.x. (PubMed PMID: 21585603).
Article CAS PubMed Google Scholar
Shin CM, Kim N, Park JH, Kang GH, Kim JS, Jung HC, Song IS. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae. J Pathol. 2012;226(4):654–65. https://doi.org/10.1002/path.2990. (PubMed PMID: 22252584).
Article CAS PubMed Google Scholar
Shin CM, Kim N, Lee HS, Park JH, Ahn S, Kang GH, et al. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study. Int J Cancer. 2013;133(9):2034–42. https://doi.org/10.1002/ijc.28219. (PubMed PMID: 23595635).
Article CAS PubMed Google Scholar
Shin CM, Kim N, Yoon H, Choi YJ, Park JH, Park YS, Lee DH. Aberrant DNA Methylation Maker for Predicting Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasms. Cancer Res Treat. 2022;54(4):1157–66. https://doi.org/10.4143/crt.2021.997. (PubMed PMID: 35038821; PubMed Central PMCID: PMC9582476).
Article CAS PubMed PubMed Central Google Scholar
Trinh BN, Long TI, Laird PW. DNA methylation analysis by MethyLight technology. Methods. 2001;25(4):456–62.
Comments (0)